Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report filed by Nanobiotix S.A., a foreign private issuer, for the month of October 2025. The filing, dated October 24, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The company is headquartered in Paris, France, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a standalone financial statement.
Material Changes
No material financial changes versus prior periods are detailed in the provided text. The filing solely references the issuance of a press release without summarizing its specific content or financial impact.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements, if present, are contained within the attached press release (Exhibit 99.1) which is not included in the input text.
Key Facts for Investor Verification
- Verify the content of the press release dated October 24, 2025, referenced as Exhibit 99.1, as the filing itself contains no operational or financial data.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.